Возраст домена | 29 лет |
Дата окончания | Истек срок регистрации |
PR | 6 |
ИКС | n/a |
Страниц в Google | 61 |
Страниц в Яндексе | 0 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 18538280 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Pharmaceuticals | Bayer - Home
n/a
n/a
UTF-8
90.22 КБ
708
5 609 симв.
4 792 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
rxlist.com | 66 | 7 |
0 | 7347 | 1874 | |
drugs.com | 53 | 7 |
0 | 3848 | 1398 | |
webmd.com | 39 | 7 |
0 | 552 | 197 | |
nih.gov | 35 | 8 |
0 | 113 | 65 | |
drugwatch.com | 35 | 6 |
10 | 269516 | 203147 | |
yahoo.com | 34 | 9 |
0 | 9 | 7 | |
mydr.com.au | 31 | 6 |
10 | 62211 | 2179 | |
canoe.ca | 28 | 7 |
200 | 130259 | 5842 | |
healthcentral.com | 26 | 6 |
0 | 51279 | 10247 | |
about.com | 26 | 7 |
0 | 7787 | 3020 | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Данные linkpad ( 13 Мая 2014 ) | |
Количество ссылок на сайт | 122 |
Количество доменов, которые ссылаются на сайт | 78 |
Количество найденных анкоров | 35 |
Исходящие (внешние) ссылки домена | 0 |
Количество доменов, на которые ссылается сайт | 0 |
Количество исходящих анкоров | 0 |
Внешние ссылки главной страницы ( 28 ) | |
bayer.com/ | Bayer Global |
bayer.com/en/Products.aspx | Products |
bayer.com/en/media.aspx | Media |
investor.bayer.com | Investors |
career.bayer.com | Careers |
oncology.bayer.com/ | Our oncology development pipeline |
healthpolicy.pharma.bayer.com//en/commitment-responsibility/... | Commitment + Responsibility Rising concerns for pharmaceutical innovation in Japan |
healthpolicy.pharma.bayer.com | Health policy |
facebook.com/376070642426985/posts/2655713001129393 | FaCEBOOK·2 months Make your voice heard! If you are a patient or a caregiver, register with Bridge2Bayer and we will get in ... |
twitter.com/BayerHealthCare/status/1187639969671720960 | twitter·1 week #DYK that psychological stress can impact #cardiovascular health? #HealthEducationWeek Why not try out some r... |
twitter.com/hashtag/DYK?src=hash | #DYK |
twitter.com/hashtag/cardiovascular?src=hash | #cardiovascular |
twitter.com/hashtag/HealthEducationWeek?src=hash | #HealthEducationWeek |
youtube.com/watch?v=7hWnuUjoDhU | youtube·1 year Fish Soup | Easy Healthy Recipes #10 |
twitter.com/hashtag/10?src=hash | #10 |
facebook.com/pharma.bayer/ | Visit us on Facebook |
twitter.com/BayerPharma | |
youtube.com/channel/UCpFVfbgn8hPyp6McG7M9-wA | |
clinicaltrials.gov/ | www.clinicaltrials.gov Clinicaltrials.gov |
clinicalstudydatarequest.com/ | www.clinicalstudydatarequest.com Data sharing portal |
news.bayer.com/baynews/baynews.nsf/id/news-overview-category... | Press center |
bayer.com/en/bayer-worldwide.aspx | Find us in your country |
presse.bayer.de/baynews/baynews.nsf/id/Bayer-Encouraging-bus... | 2019-10-30 Bayer: Encouraging business performance across all divisions – agreements signed to divest Currenta a... |
presse.bayer.de/baynews/baynews.nsf/id/US-FDA-approves-rivar... | 2019-10-14 U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients |
presse.bayer.de/baynews/baynews.nsf/id/Bayer-inks-deals-with... | 2019-10-10 Bayer inks deals with eleven startups under G4A Digital Health Partnerships program |
presse.bayer.de/baynews/baynews.nsf/id/Updated-analysis-laro... | 2019-09-28 Updated analysis for larotrectinib confirms high response rate and durable responses over three years... |
presse.bayer.de/baynews/baynews.nsf/id/Bayer-Brigham-Womens-... | 2019-09-24 Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital open joint lab for research o... |
facebook.com/pharma.bayer | |
Внутренние ссылки главной страницы ( 65 ) | |
/en/home/index.php | - |
/en/SSL/contact/index.php | Contact Us |
# | - |
/en/search/index.php | - |
/de/home/index.php | Deutsch |
/en/treatment-care/ | Care |
/en/treatment-care/heart-and-blood-disorders/ | Heart and blood disorders |
/en/treatment-care/cancer/ | Cancer |
/en/treatment-care/eye-conditions/ | Eye conditions |
/en/treatment-care/womens-health/ | Women's health |
/en/treatment-care/mens-health/ | Men's health |
/en/treatment-care/other-treatment-areas/ | Other treatment areas |
/en/treatment-care/radiology/ | Radiology |
/en/innovation-partnering/ | Partnering |
/en/innovation-partnering/facts-figures/ | Facts & figures |
/en/innovation-partnering/development-pipeline/ | Development pipeline |
/en/innovation-partnering/clinical-trials/ | Clinical trials |
/en/innovation-partnering/partnering/ | Partnering |
/en/innovation-partnering/research-and-development-areas/ | Research and Development Areas |
/en/innovation-partnering/technologies-and-trends/ | Technologies and trends |
/en/commitment-responsibility/ | Responsibility |
/en/commitment-responsibility/health-policy/ | Health Policy |
/en/commitment-responsibility/ethics-and-transparency/ | Ethics and transparency |
/en/commitment-responsibility/family-planning/ | Family planning |
/en/commitment-responsibility/neglected-diseases/ | Neglected diseases |
/en/commitment-responsibility/healthy-aging/ | Healthy Aging |
/en/commitment-responsibility/benefits-and-risks-of-drugs/ | Benefits and risks of drugs |
/en/commitment-responsibility/wewontrest/ | WeWontRest |
/en/treatment-care/report-a-side-effect/index.php | Report A Side Effect |
/en/commitment-responsibility/benefits-and-risks-of-drugs/on... | Commitment + Responsibility Patient SafetyDiscover “The Sonifex Mystery” – New online game |
/en/innovation-partnering/development-pipeline/p2x3-antagoni... | Innovation + Partnering Pipeline InsightsP2X3 Antagonists - potential treatments for endometriosis and chronic cough |
/en/treatment-care/new-treatment-for-men-with-non-metastatic... | Treatment + Care New treatment for non-metastatic castration-resistant prostate cancer approved in U.S. |
/en/commitment-responsibility/30-years-from-now/paving-the-w... | Commitment + Responsibility What will the future of healthcare look like? |
/en/commitment-responsibility/bayer-at-the-silver-economy-fo... | Commitment + Responsibility Watch the live recording of the Silver Economy Forum 2019 |
/en/treatment-care/reaching-the-next-frontier-in-oncology-tr... | Treatment + Care Reaching the Next Frontier in Oncology Treatment – Precision Medicineby Robert LaCaze |
/en/innovation-partnering/when-patients-become-our-experts/i... | Innovation + Partnering When patients become our expertsby Stefan Oelrich |
/en/innovation-partnering/artificial-intelligence-technology... | Innovation + Partnering Artificial Intelligence – Technology-driven disease prediction to advance patient careby Dr. Mic... |
/en/innovation-partnering/can-ai-improve-cardiovascular-dise... | Innovation + Partnering Artificial Intelligence – Can AI improve cardiovascular disease outcomes?by Sebastian Guth |
/en/treatment-care/cancer/test-your-cancer/index.php | Treatment + Care Genomic Cancer Testing: See the Real Picture of a Cancer Diagnosis |
/en/innovation-partnering/ai-in-drug-discovery-accelerating-... | Innovation + Partnering AI in drug discovery – Accelerating the development of new treatmentsby Joerg Moeller |
/en/innovation-partnering/artificial-intelligence-when-we-su... | Innovation + Partnering Artificial Intelligence - when we suddenly know what we don’t knowby Stefan Oelrich |
/en/innovation-partnering/how-the-immune-system-fights-cance... | Innovation + Partnering How the immune system fights cancerThe promise of immuno-oncology |
/en/innovation-partnering/starving-cancer-cells/index.php | Innovation + Partnering Starving cancer cellsTargeting cancer via its DNA |
/en/innovation-partnering/united-to-improve-patients-lives/i... | Innovation + Partnering United to improve patients’ livesAn interview with Broad Institute scientist, Steven Ferrara |
/en/innovation-partnering/harnessing-the-power-of-alpha-radi... | Innovation + Partnering Harnessing the power of alpha radiationPotential for patients with difficult-to-treat tumors |
/en/treatment-care/how-genomic-testing-helps-patients/index.... | Treatment + Care How genomic testing helps patients |
/en/treatment-care/cancer/what-is-trk-fusion-cancer/index.ph... | Treatment + Care What is TRK fusion cancer and how can we detect it? |
/en/treatment-care/cancer/testing-for-trk-fusion-cancer/inde... | Treatment + Care Testing for TRK fusion cancer |
/en/commitment-responsibility/benefits-and-risks-of-drugs/in... | Benefits and risks of drugs |
/en/treatment-care/the-first-treatment-for-trk-fusion-cancer... | Treatment + Care The first treatment for TRK fusion cancer approved by U.S. FDA |
/en/treatment-care/looking-after-yourself-while-caring-for-a... | Treatment + Care Looking after yourself while caring for a loved one |
/en/treatment-care/what-you-might-not-know-about-heart-and-b... | Treatment + Care What you might not know about heart and blood scans |
/en/innovation-partnering/the-future-of-cancer-therapy-is-no... | Innovation + Partnering The future of cancer therapy is now |
/en/treatment-care/cancer/living-with-prostate-cancer/index.... | Treatment + Care Living with prostate cancer |
/en/treatment-care/about-cancer-genomics/index.php | Treatment + Care What you need to know about cancer genomics |
/en/innovation-partnering/drug-development-the-rd-journey/in... | Innovation + Partnering From molecules to medicine Drug development: The R&D journey |
/en/commitment-responsibility/healthy-aging/index.php | Healthy aging |
/en/innovation-partnering/partnering/why-we-partner/index.ph... | Innovation + Partnering Why we partner |
/en/innovation-partnering/partnering/treating-chronic-lung-d... | Innovation + Partnering Treating chronic lung diseasesHow partnerships in research and development can help |
/en/treatment-care/approval_of_first_tumor-agnostic_therapy_... | Treatment + Care Approval of first tumor – agnostic therapy in Europe |
/microsites/csr/reports/index.php?story=6 | Argentina Chagas Disease “We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulat... |
/en/innovation-partnering/clinical-trials/trial-finder/ | Treatment + Care Bayer trial finder |
/en/conditions-of-use/index.php | Conditions of Use |
/en/privacy-statement/index.php | Privacy Statement |
/en/imprint/index.php | Imprint |
Domain Name: berlex.com
Registry Domain ID: 4301916_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: www.cscprotectsbrands.com
Updated Date: 2014-02-08 15:34:15 -0500
Creation Date: 1994-12-13 00:00:00 -0500
Registrar Registration Expiration Date: 2014-12-12 00:00:00 -0500
Registrar: CSC CORPORATE DOMAINS, INC.
Registrar IANA ID: 299
Registrar Abuse Contact Email: admin@internationaladmin.com
Registrar Abuse Contact Phone: +1.8887802723
Domain Status: clientTransferProhibited
Registry Registrant ID:
Registrant Name: WebDomain Admin
Registrant Organization: Bayer Corporation
Registrant Street: 100 Bayer Road
Registrant City: Pittsburgh
Registrant State/Province: PA
Registrant Postal Code: 15205
Registrant Country: US
Registrant Phone: +1.4127772000
Registrant Phone Ext:
Registrant Fax: +1.4127773143
Registrant Fax Ext:
Registrant Email: WebDomainAdmin@bayer.com
Registry Admin ID:
Admin Name: WebDomain Admin
Admin Organization: Bayer Corporation
Admin Street: 100 Bayer Road
Admin City: Pittsburgh
Admin State/Province: PA
Admin Postal Code: 15205
Admin Country: US
Admin Phone: +1.4127772000
Admin Phone Ext:
Admin Fax: +1.4127773143
Admin Fax Ext:
Admin Email: WebDomainAdmin@bayer.com
Registry Tech ID:
Tech Name: WebDomain Admin
Tech Organization: Bayer Corporation
Tech Street: 100 Bayer Road
Tech City: Pittsburgh
Tech State/Province: PA
Tech Postal Code: 15205
Tech Country: US
Tech Phone: +1.4127772000
Tech Phone Ext:
Tech Fax: +1.4127773143
Tech Fax Ext:
Tech Email: WebDomainAdmin@bayer.com
Name Server: pdns1.cscdns.net
Name Server: pdns2.cscdns.net
>>> Last update of WHOIS database: 2014-02-08 15:34:15 -0500 <<<
Corporation Service Company(c) (CSC) The Trusted Partner of More than 50% of the 100 Best Global Brands.
Contact us to learn more about our enterprise solutions for Global Domain Name Registration and Management, Trademark Research and Watching, Brand, Logo and Auction Monitoring, as well SSL Certificate Services and DNS Hosting.
NOTICE: You are not authorized to access or query our WHOIS database through the use of high-volume, automated, electronic processes or for the purpose or purposes of using the data in any manner that violates these terms of use. The Data in the CSC WHOIS database is provided by CSC for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. CSC does not guarantee its accuracy. By submitting a WHOIS query, you agree to abide by the following terms of use: you agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via direct mail, e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to CSC (or its computer systems). CSC reserves the right to terminate your access to the WHOIS database in its sole discretion for any violations by you of these terms of use. CSC reserves the right to modify these terms at any time.
Register your domain name at http://www.cscglobal.com
США - 207.241.148.80
About
About
HTTP/1.1 200 OK
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
HCVer: 114
Content-Type: text/html; charset=utf-8
HAVer: 124
Date: Sun, 03 Nov 2019 16:42:08 GMT
Transfer-Encoding: chunked
Connection: keep-alive
Connection: Transfer-Encoding
Set-Cookie: PHPSESSID=VR3aPTGb-mXV-Lto-cXat0; expires=Sun, 03-Nov-2019 17:42:08 GMT; Max-Age=3600; path=/; HttpOnly
Set-Cookie: WHGACE=ffffffff09b6a18945525d5f4f58455e445a4a423660;expires=Mon, 04-Nov-2019 16:42:08 GMT;path=/;httponly
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"